Primary Mediastinal B Cell Lymphoma: A Limited Institutional Experience with Uniform DAEPOCH-R Protocol.
作者信息
Gogia Ajay, Kumar Sudhir, Chellapurum Santosh Kumar, Biswas Ahitagni, Mallick Soumya
机构信息
Department of Medical Oncology, BRA, IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, Room No. 218, New Delhi, India.
Department of Radiation Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, New Delhi, India.
出版信息
Indian J Hematol Blood Transfus. 2021 Jan;37(1):176-178. doi: 10.1007/s12288-020-01301-z. Epub 2020 Jun 5.
Abstract
摘要
相似文献
1
Primary Mediastinal B Cell Lymphoma: A Limited Institutional Experience with Uniform DAEPOCH-R Protocol.原发性纵隔B细胞淋巴瘤：采用统一的DAEPOCH-R方案的有限机构经验。
Indian J Hematol Blood Transfus. 2021 Jan;37(1):176-178. doi: 10.1007/s12288-020-01301-z. Epub 2020 Jun 5.
2
A multicentre retrospective study of primary breast diffuse large B-cell and high-grade B-cell lymphoma treatment strategies and survival.一项关于原发性乳腺弥漫性大B细胞和高级别B细胞淋巴瘤治疗策略及生存情况的多中心回顾性研究。
Hematology. 2020 Dec;25(1):203-210. doi: 10.1080/16078454.2020.1769419.
3
[Eight-year experience in treating aggressive mediastinal large B-cell lymphomas].[治疗侵袭性纵隔大B细胞淋巴瘤的八年经验]
Ter Arkh. 2013;85(7):50-6.
4
[Primary mediastinal large B-cell lymphoma in pregnant women].[孕妇原发性纵隔大B细胞淋巴瘤]
Ter Arkh. 2014;86(7):53-8.
5
R-CHOP without radiation in frontline management of primary mediastinal B-cell lymphoma.R-CHOP 方案不联合放疗用于原发性纵隔 B 细胞淋巴瘤的一线治疗。
Leuk Lymphoma. 2019 May;60(5):1261-1265. doi: 10.1080/10428194.2018.1519812. Epub 2019 Jan 18.
6
Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.R-CHOP 治疗原发性纵隔大 B 细胞淋巴瘤患者的极低危亚组鉴定。
Oncologist. 2021 Jul;26(7):597-609. doi: 10.1002/onco.13789. Epub 2021 Jun 17.
7
Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphoma.在原发性纵隔 B 细胞淋巴瘤的一线治疗中，R-CHOP 联合或不联合巩固性放疗与 DA-EPOCH-R 的真实世界经验。
Cancer Med. 2019 Aug;8(10):4626-4632. doi: 10.1002/cam4.2347. Epub 2019 Jul 2.
8
Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma.纵隔灰区淋巴瘤的甲基化分析揭示了一种独特的特征，具有经典霍奇金淋巴瘤和原发性纵隔大 B 细胞淋巴瘤的共同特征。
Haematologica. 2011 Apr;96(4):558-66. doi: 10.3324/haematol.2010.033167.
9
Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B Cell Lymphoma Treated with Second-Line Therapy and Intent to Transplant.二线治疗联合移植意向治疗复发/难治性原发性纵隔（胸腺）大 B 细胞淋巴瘤的结局。
Biol Blood Marrow Transplant. 2018 Oct;24(10):2133-2138. doi: 10.1016/j.bbmt.2018.06.009. Epub 2018 Jun 15.
10
Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients.原发性纵隔 B 细胞淋巴瘤的治疗和结局：一项三十年单中心 151 例患者的经验。
Ann Hematol. 2021 Sep;100(9):2261-2268. doi: 10.1007/s00277-020-04364-0. Epub 2020 Dec 10.
引用本文的文献
1
Pediatric mediastinal lymphoma.小儿纵隔淋巴瘤
Mediastinum. 2020 Sep 30;4:22. doi: 10.21037/med-20-37. eCollection 2020.
2
Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experience.采用剂量调整R-EPOCH方案治疗的原发性纵隔B细胞淋巴瘤患者的结局：单中心经验
Indian J Hematol Blood Transfus. 2021 Jul;37(3):379-385. doi: 10.1007/s12288-020-01372-y. Epub 2021 Mar 1.
本文引用的文献
1
DA-EPOCH-R in Aggressive CD 20 Positive B Cell Lymphomas: Real-World Experience.DA-EPOCH-R方案治疗侵袭性CD20阳性B细胞淋巴瘤：真实世界经验
Indian J Hematol Blood Transfus. 2018 Jul;34(3):454-459. doi: 10.1007/s12288-017-0901-1. Epub 2017 Nov 4.
2
How I treat primary mediastinal B-cell lymphoma.我如何治疗原发性纵隔 B 细胞淋巴瘤。
Blood. 2018 Aug 23;132(8):782-790. doi: 10.1182/blood-2018-04-791566. Epub 2018 Jul 5.
3
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.接受剂量调整型EPOCH-R治疗的原发性纵隔B细胞淋巴瘤成人和儿童的治疗结果。
Br J Haematol. 2017 Dec;179(5):739-747. doi: 10.1111/bjh.14951. Epub 2017 Oct 29.
4
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial.利妥昔单抗、环磷酰胺、多柔比星、长春新碱和泼尼松龙（R-CHOP）方案治疗原发性纵隔B细胞淋巴瘤：英国国家癌症研究所R-CHOP 14与21试验的亚组分析
Br J Haematol. 2016 Nov;175(4):668-672. doi: 10.1111/bjh.14287. Epub 2016 Aug 1.
5
The 2016 revision of the World Health Organization classification of lymphoid neoplasms.《世界卫生组织淋巴组织肿瘤分类（2016年修订版）》
Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15.
6
The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients.利妥昔单抗与正电子发射断层扫描在原发性纵隔大B细胞淋巴瘤治疗中的作用：74例患者的经验
Hematol Oncol. 2015 Dec;33(4):145-50. doi: 10.1002/hon.2172. Epub 2014 Sep 25.
7
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.霍奇金淋巴瘤和非霍奇金淋巴瘤初始评估、分期及反应评估的建议：卢加诺分类
J Clin Oncol. 2014 Sep 20;32(27):3059-68. doi: 10.1200/JCO.2013.54.8800.
8
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.剂量调整的 EPOCH-利妥昔单抗治疗原发性纵隔 B 细胞淋巴瘤。
N Engl J Med. 2013 Apr 11;368(15):1408-16. doi: 10.1056/NEJMoa1214561.
9
P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines.人结肠癌细胞系中P-糖蛋白表达与阿霉素细胞毒性的时间依赖性
Int J Cancer. 1991 Nov 11;49(5):696-703. doi: 10.1002/ijc.2910490512.
Zotero 插件